Saving changes...

Done

Error

An Observation on the Superiority of Articaine versus Lidocaine in Dental Anesthesia

An Observation on the Superiority of Articaine versus Lidocaine in Dental Anesthesia

An Observation on the Superiority of Articaine versus Lidocaine in Dental Anesthesia

Fabio Velotti, M.Sc. Eng Bernardo Verrengia, C. Chem MRSC Deborah S. Laird, BS Pharm, RPh
Fabio Velotti, M.Sc. Eng Bernardo Verrengia, C. Chem MRSC Deborah S. Laird, BS Pharm, RPh
on behalf of Dental Town

$36.00 $ 36.00 $ 36.00

$36.00 $ 36.00 $ 36.00

$ 36.00 $ 36.00 $ 36.00
$ 36.00 $ 36.00 $ 36.00
Normal Price: $36.00 $36.00

Review:

Launch date: 08 Mar 2017
Expiry Date:

Last updated: 08 Mar 2017

Reference: 170244

This course is no longer available

Exam is embedded in the course
No preview available
No Exam Available

Latest User Comments

I would like to...

Course Availability

This course is only available to trainees days after purchase. It would need to be repurchased by the trainee if not completed in the allotted time period. This course is no longer available. You will need to repurchase if you wish to take the course again.

Description

This course is designed to educate the dental-health professional regarding thepotential superiority of articaine 4 percent in relation to lidocaine 2 percent in dentalanesthesia. It is also intended to illustrate the differences between these products regardingtheir chemistry, pharmacology, metabolism and use.

Objectives

Objectives
Appreciate the history of these compounds' development in dental anesthesia. Gain insight into the safety and ef? cacy of articaine and lidocaine. Consider the best choice of anesthetic for complicated dental procedures. Understand the use of articaine and lidocaine in children and geriatric patients. Understand, in detail, articaine and lidocaine's main characteristics when used in the clinic.
Fabio Velotti, M.Sc. Eng Bernardo Verrengia, C. Chem MRSC Deborah S. Laird, BS Pharm, RPh

Author Information Play Video Bio

Fabio Velotti, M.Sc. Eng Bernardo Verrengia, C. Chem MRSC Deborah S. Laird, BS Pharm, RPh
on behalf of Dental Town

Fabio Velotti, CEO of Pierrel Pharma, received his master’s in engineering from the Federico II University in Naples, Italy. In 1999, he covered several positions at Royal DSM, focusing on the development, manufacturing and commercialization of pharma biotech products. In 2011, he moved to Pierrel in order to manage Pierrel Pharmaceuticals’ products portfolio. Bernardo Verrengia received an honors degree in chemistry at The Royal Institute of Chemistry in the U.K. In 1974, he was a research analyst for Albright and Wilson in their R&D department and later worked for VG instruments as mass spectrometry applications specialist. In 1982, he moved to Italy with Pierrel Pharmaceuticals as the head of analytical chemistry in the pharmaceuticals’ R&D department. He has been actively involved in many R&D projects on new pharmacologically active chemical entities with NDA submissions and approvals in Europe, Canada, Russia and the U.S. He is currently the scientific and regulatory of?cer at Pierrel S.p.A. Deborah Laird received her Bachelor of Science degree from the St. Louis College of Pharmacy in St. Louis, Missouri. Her pharmaceutical career spans more than 30 years, 26 of which were in sales management, sales operations, sales training and state government relations with GlaxoSmithKline. Currently she serves as the North America Orabloc product manager for Pierrel Pharma SRL.

Current Accreditations

This course has been certified by or provided by the following Certified Organization/s:

  • Academy of General Dentistry (PACE)
  • 1.50 Hours

Faculty and Disclosures

Additional Contributors

null

Conflicts Declared

Conflicts of Interest declaration by Author:

null

User Reviews (0)

Go Back

Loading...


Saving changes...

Done

Error